The GLP is committed to full transparency. Download and review our Annual Report.

talking biotech

Talking Biotech: TALEN gene editing to make more nutritious food crops

, | November 12, 2017
HOST OVERVIEW
Kevin Folta: University of Florida plant geneticist Kevin Folta launched Talking Biotech in 2015.    More details

Gene editing has been the center of attention, affecting everything from plants, to mushrooms, to livestock, to human medicine. However, when we discuss gene editing we typically describe the CRISPR Cas9 system. Such tools have grabbed recent limelight. But churning in the background, the other gene editing methods have been making progress for for years, and products are moving rapidly through pipelines toward approval. Such products will soon be available from Calyxt Corporation. Calyxt Chief Science Officer Dan Voytas discusses how TALEN, a custom sequence-specific nuclease, functions in gene editing. He contrasts it with the Cas9 system and then describes the company pipeline, with products soon to be on the market. He also discusses regulation of the products derived from TALEN technology.

Related article:  'Food Evolution' movie could mark turning point in public GMO discussion

Calyxt website and pipeline here.

Visit Kevin Folta’s Talking Biotech

Follow Talking Biotech on Twitter @TalkingBiotech

Follow Kevin Folta on Twitter @kevinfolta | Facebook: Facebook.com/kmfolta/ | Lab website: Arabidopsisthaliana.com | All funding: Kevinfolta.com/transparency

Screen Shot at AMStitcher | iTunes | Player FM | TuneIn

GLP Podcast Hosts

Listen to more episodes

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend